Last Updated : August 29, 2024
Details
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted : | 19-sept-2024 |
| Stakeholder Feedback Deadline: | 26-sept-2024 |
| Final Report Posted: | 15-nov-2024 |
Last Updated : November 15, 2024
Details
| Call for patient/clinician input open | August 19, 2024 |
|---|---|
| Call for patient/clinician input closed | October 15, 2024 |
| Submission received | October 01, 2024 |
| Submission accepted | October 16, 2024 |
| Review initiated | October 17, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | January 08, 2025 |
| Deadline for sponsors comments | January 17, 2025 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | February 13, 2025 |
| Expert committee meeting (initial) | February 26, 2025 |
| Draft recommendation issued to sponsor | June 12, 2025 |
| Draft recommendation posted for stakeholder feedback | June 19, 2025 |
| End of feedback period | July 04, 2025 |
| Final recommendation issued to sponsor and drug plans | July 21, 2025 |
| Final recommendation posted | - |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | August 05, 2025 |
| CDA-AMC review report(s) posted | - |
Last Updated : August 5, 2025
Details
| Call for patient/clinician input open | 19-Aug-24 |
|---|---|
| Call for patient/clinician input closed | 15-Oct-24 |
| Submission received | 01-Oct-24 |
| Submission accepted | 16-Oct-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 17-Jan-25 |
| Deadline for sponsors comments | 29-Jan-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 28-Feb-25 |
| Expert committee meeting (initial) | 12-Mar-25 |
| Draft recommendation issued to sponsor | 25-Mar-25 |
| Draft recommendation posted for stakeholder feedback | 03-Apr-25 |
| End of feedback period | 17-Apr-25 |
| Final recommendation issued to sponsor and drug plans | 02-May-25 |
| Final recommendation posted | 21-May-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 16-May-25 |
| CDA-AMC review report(s) posted | - |
Last Updated : July 23, 2025
Details
| Call for patient/clinician input open | August 19, 2024 |
|---|---|
| Call for patient/clinician input closed | October 15, 2024 |
| Submission received | October 02, 2024 |
| Submission accepted | October 17, 2024 |
| Review initiated | October 18, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | January 09, 2025 |
| Deadline for sponsors comments | January 20, 2025 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | February 13, 2025 |
| Expert committee meeting (initial) | February 26, 2025 |
| Draft recommendation issued to sponsor | March 10, 2025 |
| Draft recommendation posted for stakeholder feedback | March 20, 2025 |
| End of feedback period | April 03, 2025 |
| Clarification: - Reconsideration: minor revisions requested by sponsor - Request for reconsideration partially accepted | |
| Final recommendation issued to sponsor and drug plans | July 08, 2025 |
| Final recommendation posted | July 24, 2025 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | July 22, 2025 |
| CDA-AMC review report(s) posted | - |
Last Updated : July 25, 2025
Details
| Call for patient/clinician input open | 16-Aug-24 |
|---|---|
| Call for patient/clinician input closed | 15-Oct-24 |
| Submission received | 29-Oct-24 |
| Submission accepted | 13-Nov-24 |
| Review initiated | 14-Nov-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 05-Feb-25 |
| Deadline for sponsors comments | 14-Feb-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 13-Mar-25 |
| Expert committee meeting (initial) | 26-Mar-25 |
| Draft recommendation issued to sponsor | 09-Apr-25 |
| Draft recommendation posted for stakeholder feedback | 17-Apr-25 |
| End of feedback period | 05-May-25 |
| Clarification: - Reconsideration: major revisions requested by sponsor | |
| Expert committee meeting | 23-Jul-25 |
Last Updated : July 24, 2025
Details
| Call for patient/clinician input open | August 14, 2024 |
|---|---|
| Call for patient/clinician input closed | October 07, 2024 |
| Submission received | October 02, 2024 |
| Submission accepted | October 17, 2024 |
| Review initiated | October 18, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | January 09, 2025 |
| Deadline for sponsors comments | January 20, 2025 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | February 13, 2025 |
| Expert committee meeting (initial) | February 26, 2025 |
| Draft recommendation issued to sponsor | March 18, 2025 |
| Draft recommendation posted for stakeholder feedback | March 27, 2025 |
| End of feedback period | April 10, 2025 |
| Clarification: - Reconsideration: major and minor revisions requested by sponsor | |
| Expert committee meeting | June 25, 2025 |
| Final recommendation issued to sponsor and drug plans | July 10, 2025 |
| Final recommendation posted | July 28, 2025 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | July 24, 2025 |
| CDA-AMC review report(s) posted | - |
Last Updated : August 5, 2025
Details
| Call for patient/clinician input open | 07-Aug-24 |
|---|---|
| Call for patient/clinician input closed | 07-Nov-24 |
| Submission received | 19-Dec-24 |
| Submission accepted | 10-Jan-25 |
| Review initiated | 13-Jan-25 |
| Draft CADTH review report(s) provided to sponsor for comment | 16-Apr-25 |
| Deadline for sponsors comments | 29-Apr-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 30-May-25 |
| Expert committee meeting (initial) | 11-Jun-25 |
| Draft recommendation issued to sponsor | - |
| Clarification: pERC recommendation held pending receipt of NOC and evaluation of the finalized submission requirements | |
| Draft recommendation posted for stakeholder feedback | - |
| End of feedback period | - |
Last Updated : June 30, 2025